Reference health
Bortezomib for treatment of therapy-refractory anti-NMDA receptor encephalitis
10/10 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
2 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 10 checked references that resolve
resolves10.1016/S1474-4422(13)70282-5
Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study
resolves10.1038/nrrheum.2011.1
Long-lived autoreactive plasma cells drive persistent autoimmune inflammation
resolves10.1136/annrheumdis-2014-206016
The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus
resolves10.1097/RHU.0000000000000210
Refractory Primary Sjögren Syndrome Successfully Treated With Bortezomib
resolves10.1016/S1470-2045(11)70081-X
Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study
resolves10.1038/nm1763
The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis
resolves10.1212/WNL.0b013e318228c136
Analysis of complement and plasma cells in the brain of patients with anti-NMDAR encephalitis
resolves10.1016/j.nbd.2016.01.008
CNS uptake of bortezomib is enhanced by P-glycoprotein inhibition: implications for spinal muscular atrophy
resolves10.1177/1078155212453752
Deaths reported from the accidental intrathecal administration of bortezomib
resolves10.4049/jimmunol.1202317
Pathogenic Long-Lived Plasma Cells and Their Survival Niches in Autoimmunity, Malignancy, and Allergy
The 2 references without a DOI — listed, not checked
no DOI — not checkedThomas A, Rauschkolb P, Gresa-Arribas N, et al. Anti-N-methyl-D-aspartate receptor encephalitis: a patient with refractory illness after 25 months of intensive immunotherapy. JAMA Neurol 2013;70:1566–1568.
no DOI — not checkedAdams J, Palombella VJ, Sausville EA, et al. Proteasome inhibitors: a novel class of potent and effective antitumor agents. Cancer Res 1999;59:2615–2622.
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1212/wnl.0000000000003536"><img src="https://citestamp.com/citestamped/10.1212/wnl.0000000000003536/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1212/wnl.0000000000003536)